The Chemoinformatics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Chemoinformatics Market:
https://www.thebusinessresearchcompany.com/report/chemoinformatics-global-market-report
According to The Business Research Company’s Chemoinformatics Global Market Report 2024, The chemoinformatics market size has grown steadily in recent years. It will grow from $4.28 billion in 2023 to $4.4 billion in 2024 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to high throughput screening (hts), data availability, drug discovery efficiency, personalized medicine, artificial intelligence (ai) and machine learning.
The chemoinformatics market size is expected to see steady growth in the next few years. It will grow to $4.94 billion in 2028 at a compound annual growth rate (CAGR) of 3.0%. The growth in the forecast period can be attributed to biological data integration, structural biology, data management and security, regulatory compliance, drug discovery efficiency. Major trends in the forecast period include high-throughput screening, structural biology integration, biological data mining, virtual chemical libraries, personalized medicine.
The surging prevalence of chronic diseases is expected to propel the growth of the chemoinformatic market going forward. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The rising number of chronic diseases such as neglected tropical diseases demands the need for new drug discoveries and the search for novel chemicals for their treatment, for which chemoinformatic is used. For instance, according to the World Health Organization, a Switzerland-based organization for international public health, between 2020 and 2030, 500 million people are expected to develop chronic diseases such as obesity, diabetes, heart diseases, or other noncommunicable diseases (NCDs) due to physical inactivity, if governments globally do no take immediate action to promote exercises. Therefore, the surging prevalence of chronic diseases is driving the demand for the chemoinformatic market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7806&type=smp
The chemoinformatics market covered in this report is segmented –
1) By Type: Chemistry, Computer Science, Information Science
2) By Application: Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications
3) By End User: Chemical and Pharmaceutical Industries, Research and Academic Institution, Other End Users
Technological advances are a key trend gaining popularity in the chemoinformatic market. Major companies operating in the market are developing software and platforms with advanced technologies to sustain their position in the market. For instance, in January 2021, Optibrium, a UK-based developer of software for drug discovery launched the latest version of StarDropTM, a comprehensive software platform for small molecule creation, optimization, and data analysis. The latest update, StarDrop 7.0, gives drug discovery scientists access to unique artificial intelligence (AI) technology capabilities while also extending the software’s compound design techniques, delivering improved workflows, and integrating with Optibrium’s CerellaTM platform. Intuitive processes that speed up discovery cycles and cut expenses while focusing on high-quality compounds are provided by StarDrop 7.0’s seamless integration with Cerella, Optibrium’s recently launched AI technology software platform.
The chemoinformatics market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
